期刊文献+

我国制药企业国际化经营形势分析及策略探讨 被引量:4

Study of the Situation and the Strategy of Internationized Management of Chinese Pharmaceutical Enter-prises
下载PDF
导出
摘要 目的 :为提高我国制药企业的竞争力提供参考。方法 :运用国际化经营与战略管理的原理和研究方法分析我国制药企业国际化经营的现状与优劣势 ,并提出国际化经营的策略。结果与结论 :我国制药企业面临着国际化经营的机遇与挑战 ,只有通过合理、集约、集群和国际化经营 。 OBJECTIVE:To provide reference material for improving the competitive capacity of pharmaceutical enterˉprises in China.METHODS:Using the general principle of internationized management theory,the present situation,superiority and inferiority of China's pharmaceutical enterprises in management were analysed,and the strategy of internationized manˉagement was put forward.RESULTS&CONCLUSION:China's pharmaceutical enterprises are facing opportunity and chalˉlenge,only through rational,large-scaled,concentrated and internationized management can their market competitive power be raised.
出处 《中国药房》 CAS CSCD 2003年第10期582-584,共3页 China Pharmacy
关键词 制药企业 国际化经营 形势 策略 pharmaceutical enterprise internationized management situation strategy
  • 相关文献

参考文献1

二级参考文献5

  • 1肯尼斯·W·克拉克森等:《产业组织:理论·证据和公共政策》,上海三联书店,1982年.
  • 2D. A. Hay and G. S. Liu, 1997: What difference does competition make? The Economic Journal, Vol. 107.
  • 3David Greenaway, Robert Hine and Chris Milmer, 1995: Vertical and horizontal intra- industry trade, Economic Journal, Vol. 105.
  • 4Scherer Ross, 1990: Industrial market structure and economics performance, 3th edition, Houghton Mifflin Company.
  • 5斯.,约E,曹岚.东亚经济奇迹的启示—产业政策[J].经济译文,1997(4):47-50. 被引量:1

共引文献14

同被引文献34

  • 1钟敏.未来的重磅炸弹级药物[J].上海医药,2006,27(2):80-83. 被引量:3
  • 2陆国庆,吴雪钗,胡婷婷.恩必普[J].中国新药杂志,2006,15(7):572-573. 被引量:54
  • 3冯国忠,孟令杰.国际创新药物研究与产业化开发的特点与趋势[J].生物技术产业,2006(4):94-97. 被引量:2
  • 4国家“十二五”科学技术发展规划[EB/OL].[2012-05-28] http ://www. most. gov. cn/kjgh/.
  • 5Garnier J.Rebuilding the R&D engine in big pharma.Harvard Business Review,2008,86(5):68.
  • 6DiMasi J A,Hansen R W,Grabowski H G.The price of innovation:new estimates of drug development costs.J Health Econ,2003,22(2):151-186.
  • 7Trouiller P,Olliaro P,Torreele E,et al.Drug development for neglected diseases:a deficient market and a public-health policy failure.The Lancet,2002,359(9324):2188-2194.
  • 8Bunnage M E.Getting pharmaceutical R&D back on target.Nature Chemical Biology,2011,7(6):335.
  • 9http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/Documents/The_Global_Use_of_Medicines_Report.pdf.
  • 10http://info.pharmacy.hc360.com/2012/08/231016416680.shtml.

引证文献4

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部